Glaukos Corp (GKOS)
105.01
-1.50
(-1.41%)
USD |
NYSE |
May 06, 16:00
105.01
0.00 (0.00%)
After-Hours: 20:00
Glaukos Research and Development Expense (Quarterly): 30.73M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 30.73M |
| December 31, 2023 | 37.06M |
| September 30, 2023 | 33.30M |
| June 30, 2023 | 33.23M |
| March 31, 2023 | 35.17M |
| December 31, 2022 | 35.81M |
| September 30, 2022 | 28.87M |
| June 30, 2022 | 31.71M |
| March 31, 2022 | 26.88M |
| December 31, 2021 | 26.68M |
| September 30, 2021 | 28.85M |
| June 30, 2021 | 24.26M |
| March 31, 2021 | 21.22M |
| December 31, 2020 | 21.24M |
| September 30, 2020 | 20.30M |
| June 30, 2020 | 18.97M |
| March 31, 2020 | 24.87M |
| December 31, 2019 | 20.03M |
| September 30, 2019 | 17.28M |
| June 30, 2019 | 17.07M |
| March 31, 2019 | 13.93M |
| Date | Value |
|---|---|
| December 31, 2018 | 12.96M |
| September 30, 2018 | 13.20M |
| June 30, 2018 | 12.61M |
| March 31, 2018 | 10.91M |
| December 31, 2017 | 10.52M |
| September 30, 2017 | 9.805M |
| June 30, 2017 | 9.633M |
| March 31, 2017 | 8.942M |
| December 31, 2016 | 7.399M |
| September 30, 2016 | 7.807M |
| June 30, 2016 | 6.955M |
| March 31, 2016 | 7.062M |
| December 31, 2015 | 6.295M |
| September 30, 2015 | 6.173M |
| June 30, 2015 | 7.339M |
| March 31, 2015 | 5.24M |
| December 31, 2014 | 5.308M |
| September 30, 2014 | 5.093M |
| June 30, 2014 | 4.422M |
| March 31, 2014 | 4.383M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
17.07M
Minimum
Jun 2019
37.06M
Maximum
Dec 2023
26.68M
Average
26.78M
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp | 366.00M |
| Globus Medical Inc | 52.25M |
| PROCEPT BioRobotics Corp | 13.08M |
| Accuray Inc | 10.91M |
| Asensus Surgical Inc | 8.614M |